Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal Indonesian Journal of Health Sciences Research and Development (IJHSRD)
Ritu Chauhan
Sanskar College Of pharmacy and Research
Health Professions Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Design And Evaluation Of Teneligliptin Tablet: Teneligliptin Tablet Ritu Chauhan; Anuradha Verma; Tushar Singhal; Anshika Garg; Babita Kumar; Dayanidhi Pandey
INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD) Vol. 5 No. 1 (2023): INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT
Publisher : STIKes Mandala Waluya Kendari

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36566/ijhsrd/Vol5.Iss1/153

Abstract

Background : Excessive workload, stress, and, genetic disorders are the main reason for the increasing prevalence of Type II diabetes in India. Teneligliptin, is a potent Dipeptidyl peptidase (DPP-4) inhibitor that exerts its action in Type II diabetes mellitus. Teneligliptin mainly acts by increasing insulin levels and decreasing glucagon levels in the circulation in a glucose-dependent manner. It offers sufficient glycemic control in a period of 12 weeks ad is also tolerable by renal-impaired patients. Methods: Six formulations of teneligliptin tablets were prepared by using different ratios of MCC, maize starch, HPMC, HPC, aerosol, and magnesium stearate. The prepared tablets were evaluated in terms of friability, hardness, disintegration, and dissolution rate profile Results: Out of all six formulations, F4 reflects better tablet characteristics as compared to the rest five formulations Conclusions: F4 turns out to be the best formulation of the present study and can be used for commercial production.
Design And Evaluation Of Teneligliptin Tablet: Teneligliptin Tablet Ritu Chauhan; Anuradha Verma; Tushar Singhal; Anshika Garg; Babita Kumar; Dayanidhi Pandey
INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD) Vol. 5 No. 1 (2023): INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT
Publisher : STIKes Mandala Waluya Kendari

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36566/ijhsrd/Vol5.Iss1/153

Abstract

Background : Excessive workload, stress, and, genetic disorders are the main reason for the increasing prevalence of Type II diabetes in India. Teneligliptin, is a potent Dipeptidyl peptidase (DPP-4) inhibitor that exerts its action in Type II diabetes mellitus. Teneligliptin mainly acts by increasing insulin levels and decreasing glucagon levels in the circulation in a glucose-dependent manner. It offers sufficient glycemic control in a period of 12 weeks ad is also tolerable by renal-impaired patients. Methods: Six formulations of teneligliptin tablets were prepared by using different ratios of MCC, maize starch, HPMC, HPC, aerosol, and magnesium stearate. The prepared tablets were evaluated in terms of friability, hardness, disintegration, and dissolution rate profile Results: Out of all six formulations, F4 reflects better tablet characteristics as compared to the rest five formulations Conclusions: F4 turns out to be the best formulation of the present study and can be used for commercial production.
Co-Authors Anshika Garg Anuradha Verma Babita Kumar Dayanidhi Pandey Tushar Singhal